Baxter Completes Acquisition of Claris Injectables, Expanding Generic Injectable Medicines Portfolio

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/28/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. NVDA
10. FDXF

Go back to Baxter Completes Acquisition of Claris Injectables, Expanding Generic Injectable Medicines Portfolio

Baxter International (BAX) PT Raised to $68 at Cowen

July 27, 2017 8:26 AM EDT

Cowen raised its price target on Baxter International (NYSE: BAX) to $68.00 (from $66.00) while maintaining a Market Perform rating. BAX delivered impressive 2Q results that showed upside to Street forecasts for sales, gross margin, operating margin and adjusted EPS. For earnings, the company anticipates generating... More